Total Payments
$14,821
2024 Payments
$20.95
Companies
53
Transactions
1,101
Medicare Patients
2,188
Medicare Billing
$135,433
Payment Breakdown by Category
Food & Beverage$14,807 (99.9%)
Education$14.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,807 | 1,099 | 99.9% |
| Education | $14.25 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,510 | 200 | $0 (2023) |
| Novo Nordisk Inc | $1,559 | 142 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,301 | 79 | $0 (2023) |
| Lilly USA, LLC | $1,290 | 121 | $0 (2023) |
| ABBVIE INC. | $954.23 | 79 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $885.79 | 59 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $669.00 | 59 | $0 (2023) |
| Gilead Sciences, Inc. | $550.13 | 33 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $529.48 | 37 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $492.61 | 36 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.95 | 1 | Abbott Laboratories ($20.95) |
| 2023 | $2,251 | 148 | GlaxoSmithKline, LLC. ($478.38) |
| 2022 | $2,389 | 136 | GlaxoSmithKline, LLC. ($400.94) |
| 2021 | $1,712 | 110 | Novo Nordisk Inc ($277.71) |
| 2020 | $1,814 | 123 | GlaxoSmithKline, LLC. ($287.56) |
| 2019 | $2,362 | 206 | GlaxoSmithKline, LLC. ($359.25) |
| 2018 | $2,397 | 205 | GlaxoSmithKline, LLC. ($451.69) |
| 2017 | $1,876 | 172 | AstraZeneca Pharmaceuticals LP ($392.98) |
All Payment Transactions
1,101 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Vascular | ||||||
| 09/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Neuromodulation | ||||||
| 09/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardio-renal | ||||||
| 09/26/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Diabetes | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 09/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Biological | ||||||
| 09/16/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.70 | General |
| 09/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: PAIN | ||||||
| 09/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Neuroscience | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Oncology | ||||||
| 09/06/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: PAIN | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Gastroenterology | ||||||
| 09/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Diabetes | ||||||
| 08/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.63 | General |
| 08/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 08/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: INSOMNIA | ||||||
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.06 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 609 | 697 | $61,981 | $36,593 |
| 2022 | 10 | 729 | 809 | $55,541 | $41,706 |
| 2021 | 11 | 454 | 548 | $41,899 | $30,507 |
| 2020 | 8 | 396 | 495 | $40,052 | $26,627 |
Total Patients
2,188
Total Services
2,549
Medicare Billing
$135,433
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 136 | $20,854 | $11,465 | 55.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $17,112 | $11,186 | 65.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 149 | $15,864 | $7,746 | 48.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,621 | $1,439 | 54.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 73 | 73 | $1,433 | $1,395 | 97.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 65 | 65 | $1,256 | $1,242 | 98.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 25 | 27 | $1,086 | $927.06 | 85.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 19 | 19 | $489.64 | $488.31 | 99.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 30 | $636.00 | $486.60 | 76.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 96 | 100 | $628.50 | $218.16 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 114 | 114 | $14,987 | $14,766 | 98.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 148 | 202 | $17,270 | $11,079 | 64.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 107 | $12,681 | $7,282 | 57.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $2,933 | $2,699 | 92.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 107 | 107 | $2,225 | $2,060 | 92.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 88 | 88 | $1,813 | $1,663 | 91.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 25 | $1,294 | $1,054 | 81.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 27 | 27 | $773.45 | $702.21 | 90.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 98 | 104 | $913.50 | $230.86 | 25.3% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 17 | 19 | $651.65 | $171.45 | 26.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 72 | 72 | $9,327 | $9,327 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 175 | $13,584 | $8,128 | 59.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 102 | $11,411 | $7,019 | 61.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 15 | 15 | $2,858 | $2,567 | 89.8% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 19 | 19 | $857.47 | $784.89 | 91.5% |
About Dr. Michael Rie, M.D
Dr. Michael Rie, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902009301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Rie, M.D has received a total of $14,821 in payments from pharmaceutical and medical device companies, with $20.95 received in 2024. These payments were reported across 1,101 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($14,807).
As a Medicare-enrolled provider, Rie has provided services to 2,188 Medicare beneficiaries, totaling 2,549 services with total Medicare billing of $135,433. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 06/06/2007
- Last Updated 03/14/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902009301
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,132
- JARDIANCE (Drug) $853.72
- FARXIGA (Drug) $567.20
- XIFAXAN (Drug) $545.60
- SHINGRIX (Biological) $512.43
- Ozempic (Drug) $502.70
- TRULICITY (Drug) $498.70
- ANORO (Drug) $373.23
- Trintellix (Drug) $305.38
- Kerendia (Drug) $299.22
- Victoza (Drug) $293.51
- XYWAV (Drug) $291.65
- VRAYLAR (Drug) $281.85
- Vascepa (Drug) $260.78
- TRINTELLIX (Drug) $257.52
- Saxenda (Drug) $248.61
- NURTEC ODT (Drug) $245.46
- EMGALITY (Drug) $245.35
- BREO (Drug) $244.03
- MYRBETRIQ (Drug) $232.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Family Medicine $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
Family Medicine $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Family Medicine $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Family Medicine $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Family Medicine $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768
Family Medicine $32,768